Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
Smith & Nephew Plc Stock Quote

Smith & Nephew Plc (NYSE: SNN)

$23.92
(0.5%)
$0.12
Price as of April 17, 2024, 4:00 p.m. ET

Smith & Nephew Plc Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
SNN -16.90% -28.85% -6.58% +340%
S&P +20.88% +72.88% +11.56% +254%

Smith & Nephew Plc Company Info

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics; Sports Medicine and ENT; and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies and ENT. The Advanced Wound Management segment comprises advanced wound care, advanced wound bioactives and advanced wound devices businesses. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.

News & Analysis

The Fool has written over 100 articles on Smith & Nephew Plc.

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.